A Clinical Stage Biotechnology Company Caelum Biosciences is developing treatments for AL Amyloidosis, a rare and life-threatening hematologic disorder. LEARN MORE Have you recently been diagnosed with AL Amyloidosis?FIND A TRIAL NEAR YOU Caelum Biosciences has two ongoing Phase 3 clinical trials to determine if CAEL-101 has a benefit in patients with severe Cardiac AL Light Chain Amyloidosis
Caelum Biosciences has two ongoing Phase 3 clinical trials to determine if CAEL-101 has a benefit in patients with severe Cardiac AL Light Chain Amyloidosis